4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Seaport Therapeutics, Inc. (SPTX) operates in the Biotechnology industry and is headquartered in Boston, United States with about 58 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, SPTX reported $0M in revenue and ($75M) in net income.
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | $0M | $0M |
| Operating Income (EBIT) | ($87M) | ($52M) |
| Net Income | ($75M) | ($47M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Total Revenue | $0M | $0M |
| Operating Income (EBIT) | ($28M) | ($16M) |
| Net Income | ($25M) | ($13M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Assets | $249M | $316M |
| Total Liabilities | $342M | $341M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SPTX viewer.
About TickerBase · Data methodology & sources